St. Jude wins heart valve approval; EU battle rages over device approval system changes;

 @FierceMedDev: Post-PMA, Cardiovascular Systems pursues public offering. More | Follow @FierceMedDev

 @MarkHFierce: Spurned by Illumina, Roche may have found a new gene sequencer/Dx company to love. But at what price? Story | Follow @MarkHFierce

 @DamianFierce: With election long passed, device tax lobbyists ply Dems. Article | Follow @DamianFierce

> Smith & Nephew ($SNN) is rolling out a new modular rail system treatment designed for external bone fixation and deformity correction. Item

> Johnson & Johnson/Ethicon ($JNJ) won FDA 510(k) clearance for its new Enseal G2 cordless tissue sealer device. Release

> St. Jude Medical ($STJ) won FDA approval for its new Trifecta valve, which is designed to replace diseased, damaged or malfunctioning aortic heart valves. Release

> nContact, a maker of catheter and surgical ablation devices has raised $6.7 million out of a $13 million fundraising goal. Story

> Hatch Medical secured two U.S. patents regarding its percutaneous spinal stabilization system. Release

> Conflict continues between the European Parliament and European Commission over plans to develop a centralized medical device approval system more like the U.S. model. Story

Biotech News

 @FierceBiotech: Amgen scores PhIII success with BioVex virus against melanoma. More | Follow @FierceBiotech

 @JohnCFierce: AstraZeneca feels sting of union backlash against R&D upheaval. Story | Follow @JohnCFierce

 @RyanMFierce: Merck slashes data-management costs with China site. Article | Follow @RyanMFierce

> Volatile BioLineRx shares decimated by PhII/III schizophrenia drug failure. Story

> Lone Star biotech banks $11.4M for PhII orphan drug odyssey. Article

> Amgen scores PhIII success with BioVex virus against melanoma. News

Pharma News

 @FiercePharma: FDA Commish Hamburg taps acting chief of generics office. Kathleen Uhl was former head's senior adviser. Report | Follow @FiercePharma

 @EricPFierce: Italy's the 2nd largest API maker behind China, says Italian expert. Who would have guessed it? India is 3rd. More | Follow @EricPFierce

> Valeant nabs skin-care specialist Obagi for $344M. News

> Merck KGaA, Bristol-Myers plan joint assault on China's diabetes market. More

> Reuters: Roche jumps into bidding for lab equipment maker Life Tech. Story

Biomarkers News

> Luminex to collaborate with Merck on Alzheimer's biomarker diagnostic. Report

> Mount Sinai wins $5M to study vocal disorder biomarkers. Item

> Pee in a cup to diagnose gastroesophageal cancer. More

> GenoMine test spots three new kidney cancer biomarkers. Article

> Texas research team spots Barrett's esophagus biomarkers. Story

Drug Delivery News

 @MichaelGFierce: Spectrum picks up orphan cancer drug with stabilized delivery. More | Follow @MichaelGFierce

> New nanomed reduces inflammation in injured tissue by natural means. Story

> Delivery gel releases drugs in response to pressure. More

> Shire bets on PhII protein-delivery therapy to fight infant blindness. Article

> Needle-free ear infection patch delivers bacteria-killing vaccine. Item

Suggested Articles

The randomized, blinded study showed statistically significant improvements in assessments of inattention and brain activity.

U.K.-based surgery robot developer CMR Surgical has begun rolling out its Versius platform to the NHS, completing its first procedures in Europe.

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.